In a second study of 30 CBF-AML patients with a median age of 40 years, and medical conditions that made them ineligible for intensive chemotherapy (generally active infections), treated with one cycle of venetoclax and HMA, 70% achieved CR/CRi [78]. Here, CEBPZ is linked to acute myeloid leukemia.